Clinical trials
Observational Myelodysplastic Syndromes trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
94 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2004 | 3 |
| 2006 | 7 |
| 2007 | 11 |
| 2008 | 7 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 2 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 7 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
| Recruiting | 22 |
| Terminated | 11 |
| Unknown status | 5 |
| Enrolling by invitation | 3 |
| Active, not recruiting | 3 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 6 |
| Fred Hutchinson Cancer Center | 5 |
| M.D. Anderson Cancer Center | 5 |
| Celgene | 4 |
| City of Hope Medical Center | 4 |
| Dana-Farber Cancer Institute | 4 |
| Bristol-Myers Squibb | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| OHSU Knight Cancer Institute | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 94 |
| Leukemia, Myeloid, Acute | 45 |
| Leukemia | 36 |
| Multiple Myeloma | 28 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 28 |
| Lymphoma | 24 |
| Lymphoma, Non-Hodgkin | 24 |
| Myeloproliferative Disorders | 23 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 22 |
| Hodgkin Disease | 20 |
Trials
Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.